Kentucky Retirement Systems’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.99M | Sell |
6,406
-78
| -1% | -$53.1K | 0.1% | 181 |
|
|
2026
Q1 | $1.78M | Sell |
6,484
-64
| -1% | -$49K | 0.13% | 189 |
|
|
2025
Q4 | $5.05M | Hold |
6,548
| – | – | 0.14% | 131 |
|
|
2025
Q3 | $3.68M | Sell |
6,548
-150
| -2% | -$84.8K | 0.1% | 181 |
|
|
2025
Q2 | $3.52M | Sell |
6,698
-439
| -6% | -$245K | 0.1% | 186 |
|
|
2025
Q1 | $4.53M | Sell |
7,137
-155
| -2% | -$107K | 0.14% | 146 |
|
|
2024
Q4 | $5.19M | Sell |
7,292
-101
| -1% | -$84.8K | 0.15% | 122 |
|
|
2024
Q3 | $7.77M | Sell |
7,393
-600
| -8% | -$668K | 0.23% | 84 |
|
|
2024
Q2 | $8.4M | Sell |
7,993
-30
| -0.4% | -$29.1K | 0.24% | 81 |
|
|
2024
Q1 | $7.72M | Sell |
8,023
-548
| -6% | -$521K | 0.23% | 92 |
|
|
2023
Q4 | $7.53M | Buy |
8,571
+85
| +1% | +$70K | 0.24% | 94 |
|
|
2023
Q3 | $6.98M | Sell |
8,486
-189
| -2% | -$149K | 0.24% | 89 |
|
|
2023
Q2 | $6.23M | Buy |
8,675
+175
| +2% | +$135K | 0.21% | 101 |
|
|
2023
Q1 | $6.98M | Buy |
8,500
+73
| +0.9% | +$55.1K | 0.26% | 89 |
|
|
2022
Q4 | $6.08M | Buy |
8,427
+36
| +0.4% | +$26.6K | 0.24% | 98 |
|
|
2022
Q3 | $5.78M | Buy |
8,391
+373
| +5% | +$235K | 0.25% | 88 |
|
|
2022
Q2 | $4.74M | Buy |
8,018
+1,216
| +18% | +$790K | 0.2% | 111 |
|
|
2022
Q1 | $4.75M | Sell |
6,802
-94
| -1% | -$59.5K | 0.19% | 108 |
|
|
2021
Q4 | $4.36M | Buy |
6,896
+788
| +13% | +$484K | 0.18% | 117 |
|
|
2021
Q3 | $3.7M | Buy |
6,108
+11
| +0.2% | +$6.83K | 0.17% | 123 |
|
|
2021
Q2 | $3.4M | Sell |
6,097
-148
| -2% | -$75K | 0.16% | 131 |
|
|
2021
Q1 | $2.96M | Sell |
6,245
-75
| -1% | -$36.5K | 0.14% | 146 |
|
|
2020
Q4 | $3.05M | Buy |
6,320
+236
| +4% | +$127K | 0.16% | 134 |
|
|
2020
Q3 | $3.41M | Buy |
6,084
+469
| +8% | +$284K | 0.21% | 104 |
|
|
2020
Q2 | $3.5M | Buy |
5,615
+159
| +3% | +$90.3K | 0.25% | 88 |
|
|
2020
Q1 | $2.66M | Buy |
5,456
+1,346
| +33% | +$555K | 0.18% | 129 |
|
|
2019
Q4 | $1.54M | Buy |
4,110
+15
| +0.4% | +$5.05K | 0.11% | 196 |
|
|
2019
Q3 | $1.14M | Buy |
4,095
+433
| +12% | +$128K | 0.09% | 244 |
|
|
2019
Q2 | $1.15M | Buy |
3,662
+235
| +7% | +$78.2K | 0.1% | 223 |
|
|
2019
Q1 | $1.41M | Buy |
3,427
+51
| +2% | +$21K | 0.14% | 170 |
|
|
2018
Q4 | $1.26M | Buy |
3,376
+76
| +2% | +$27.8K | 0.14% | 168 |
|
|
2018
Q3 | $1.33M | Buy |
3,300
+16
| +0.5% | +$6.09K | 0.13% | 181 |
|
|
2018
Q2 | $1.13M | Sell |
3,284
-746
| -19% | -$233K | 0.12% | 196 |
|
|
2018
Q1 | $1.39M | Sell |
4,030
-721
| -15% | -$251K | 0.12% | 199 |
|
|
2017
Q4 | $1.79M | Buy |
4,751
+72
| +2% | +$29.2K | 0.13% | 186 |
|
|
2017
Q3 | $2.09M | Sell |
4,679
-206
| -4% | -$98K | 0.16% | 156 |
|
|
2017
Q2 | $2.4M | Buy |
4,885
+10
| +0.2% | +$4.38K | 0.18% | 135 |
|
|
2017
Q1 | $1.89M | Sell |
4,875
-611
| -11% | -$226K | 0.15% | 168 |
|
|
2016
Q4 | $2.01M | Sell |
5,486
-2,415
| -31% | -$918K | 0.14% | 172 |
|
|
2016
Q3 | $3.18M | Buy |
7,901
+1,268
| +19% | +$509K | 0.21% | 114 |
|
|
2016
Q2 | $2.32M | Sell |
6,633
-540
| -8% | -$208K | 0.15% | 157 |
|
|
2016
Q1 | $2.58M | Buy |
7,173
+1,276
| +22% | +$526K | 0.16% | 152 |
|
|
2015
Q4 | $3.2M | Buy |
5,897
+592
| +11% | +$321K | 0.24% | 102 |
|
|
2015
Q3 | $2.47M | Buy |
5,305
+218
| +4% | +$117K | 0.21% | 116 |
|
|
2015
Q2 | $2.6M | Buy |
5,087
+121
| +2% | +$59K | 0.21% | 121 |
|
|
2015
Q1 | $2.24M | Sell |
4,966
-551
| -10% | -$234K | 0.18% | 137 |
|
|
2014
Q4 | $2.26M | Sell |
5,517
-223
| -4% | -$87.7K | 0.17% | 148 |
|
|
2014
Q3 | $2.07M | Buy |
+5,740
| New | +$1.92M | 0.15% | 161 |
|
|
2014
Q1 | $1.96M | Buy |
6,528
+44
| +0.7% | +$13.6K | 0.14% | 178 |
|
|
2013
Q4 | $1.78M | Buy |
6,484
+4
| +0.1% | +$1.15K | 0.13% | 189 |
|
|
2013
Q3 | $2.03M | Buy |
+6,480
| New | +$1.7M | 0.16% | 146 |
|
Other funds holding REGN
Kentucky Retirement Systems's REGN Position: Q2 2026 in Review
Kentucky Retirement Systems reduced its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q2 2026, selling an estimated $53.1K and leaving 6,406 shares worth $3.99M. The position accounts for 0.1% of the portfolio, ranked #181.
Kentucky Retirement Systems first reported a position in REGN in Q3 2013 and has held it in 51 quarters since. The position peaked at $8.4M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Kentucky Retirement Systems held 6,406 shares of Regeneron Pharmaceuticals worth $3.99M as of Q2 2026.
- Kentucky Retirement Systems sold 78 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $53.1K.
- Regeneron Pharmaceuticals made up 0.1% of Kentucky Retirement Systems's portfolio in Q2 2026, its #181 holding.
- Kentucky Retirement Systems first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 51 quarters since.
- Kentucky Retirement Systems's Regeneron Pharmaceuticals position peaked at $8.4M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Kentucky Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.